Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Lindsay Machen, Reza Razeghinejad & Jonathan S. Myers. (2020) Fixed-combination topical anti-hypertensive ophthalmic agents. Expert Opinion on Pharmacotherapy 21:10, pages 1269-1282.
Read now
Read now
Jed Asher Lusthaus & Ivan Goldberg. (2017) Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation. Expert Opinion on Drug Safety 16:9, pages 1071-1078.
Read now
Read now
Romeo Altafini, Maria-Luise Scherzer, Douglas A Hubatsch & Paolo Frezzotti. (2015) Brinzolamide 1%/timolol versus dorzolamide 2%/timolol in the treatment of open-angle glaucoma or ocular hypertension: prospective randomized patient-preference study. Clinical Ophthalmology 9, pages 2263-2270.
Read now
Read now
Kenji Inoue, Minako Shiokawa, Kyoko Ishida & Goji Tomita. (2015) Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops. Clinical Ophthalmology 9, pages 619-623.
Read now
Read now
Yoshie Shimizu, Shunsuke Nakakura, Makiko Nishiyama, Hitoshi Tabuchi & Yoshiaki Kiuchi. (2015) Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog. Clinical Ophthalmology 9, pages 475-482.
Read now
Read now
Keiji Yoshikawa, Jun Kozaki & Hidetaka Maeda. (2014) Efficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension. Clinical Ophthalmology 8, pages 389-399.
Read now
Read now
Mikio Nagayama, Toru Nakajima & Junji Ono. (2014) Safety and efficacy of a fixed versus unfixed brinzolamide/timolol combination in Japanese patients with open-angle glaucoma or ocular hypertension. Clinical Ophthalmology 8, pages 219-228.
Read now
Read now
Masayuki Nakajima, Naoki Iwasaki & Masaki Adachi. (2014) Phase III safety and efficacy study of long-term brinzolamide/timolol fixed combination in Japanese patients with open-angle glaucoma or ocular hypertension. Clinical Ophthalmology 8, pages 149-156.
Read now
Read now
Elad Moisseiev, Shimon Kurtz, Moshe Lazar & Gabi Shemesh. (2013) Intraocular pressure reduction using a fixed combination of timolol maleate 0.5% and brimonidine tartrate 0.2% administered three times daily. Clinical Ophthalmology 7, pages 1269-1273.
Read now
Read now
Ana Sanseau, Juan Sampaolesi, Emilio Rintaro Suzuki$suffix/text()$suffix/text(), Joao Franca Lopes & Hector Borel. (2013) Preference for a fixed combination of brinzolamide/timolol versus dorzolamide/timolol among patients with open-angle glaucoma or ocular hypertension. Clinical Ophthalmology 7, pages 357-362.
Read now
Read now
Leopoldo Martín Baiza-Durán, Juan Francisco Llamas-Moreno & Clotilde Ayala-Barajas. (2012) Comparison of timolol 0.5% + brimonidine 0.2% + dorzolamide 2% versus timolol 0.5% + brimonidine 0.2% in a Mexican population with primary open-angle glaucoma or ocular hypertension. Clinical Ophthalmology 6, pages 1051-1055.
Read now
Read now
Articles from other publishers (6)
A. V. SidorovaA. V. StarostinaK. S. BurlakovE. A. KokaevaI. A. Buldakov. (2023) Evaluation of the efficacy and tolerability of 1% brinzolamide and 0.5% timolol fixed combination in the treatment of primary open-angle glaucoma. National Journal glaucoma 22:1, pages 85-91.
Crossref
Crossref
I.A. Loskutov, N.E. Kolotilina, M.Yu. Bleskina, A.B. Lisitsyn & A.A. Poromov. (2022) Efficacy and safety of a fixed combination drug Brinzolol Duo in the treatment of patients with primary open-angle glaucoma. Vestnik oftal'mologii 138:6, pages 99.
Crossref
Crossref
V. P. Fokin, S. V. Balalin & A. S. Balalin. (2021) Efficiency of brinzolamide and its combinations with timolol maleate in the treatment of primary open-angle glaucoma. National Journal glaucoma 20:3, pages 78-85.
Crossref
Crossref
N. I. Kurysheva. (2020) Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part II. Ophthalmology in Russia 17:4, pages 676-682.
Crossref
Crossref
S. Yu. Petrov, V. S. Zinina & A. V. Volzhanin. (2018) The role of fixed dose combinations in the treatment of primary open-angle glaucoma. Vestnik oftal'mologii 134:4, pages 100.
Crossref
Crossref
Anton Hommer, Douglas A. Hubatsch & Juan Cano-Parra. (2015) Safety and Efficacy of Adding Fixed-Combination Brinzolamide/Timolol Maleate to Prostaglandin Therapy for Treatment of Ocular Hypertension or Glaucoma. Journal of Ophthalmology 2015, pages 1-7.
Crossref
Crossref